TRX-818 sodium ( Foslinanib sodium )

产品货号. M11046 CAS No. 1256037-62-3

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

TRX-818 sodium
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

TRX-818 钠（Foslinanib 钠）是一种口服生物药，具有潜在的抗肿瘤和抗血管生成拟态 (VM) 活性。
产品描述

TRX-818 sodium (Foslinanib sodium ) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, induces cancer cell apoptosis and inhibits cancer cell proliferation; also prevents tumor cell VM by blocking the formation of vasculogenic-like tubular structures through an as of yet undetermined mechanism of action.Liver Cancer Phase 2 Clinical.
体外实验

——
体内实验

——
同义词

Foslinanib sodium
通路

Others
靶点

Other Targets
受体

Other Targets
研究领域

Cancer
适应症

Liver Cancer

CAS Number

1256037-62-3
分子量

393.218
分子式

C16H11FNNa2O5P
纯度

>98% (HPLC)
溶解度

——
SMILES

COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)([O-])[O-].[Na+].[Na+]
化学全称

sodium (2-(3-fluorophenyl)-6-methoxy-4-oxo-1,4-dihydroquinolin-5-yl)phosphonate

计算器

产品手册

关联产品

OD1

Potent rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator (EC50 values are 7, 10 and 47 nM, respectively). Exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5 (EC50 values >3 μM). Inhibits fast inactivation on all channels. Increases peak currents at all voltages and stimulates a persistent Na+ current at hNav1.7 channel. Increases hyperpolarization at Nav1.4 and Nav1.6 channels. Induces spontaneous pain in vivo.
Bisoxatin

Bisoxatin (LA 271A) is an oral laxative that can be used to study contact laxatives for chronic constipation.
Dihydroparadol

The herbs of Zingiber officinale.